We previously showed that DUSP6 was exclusively cytoplasmic in primary HER2+ER−PR− breast cancers from metastatic breast cancer patients, with no nuclear DUSP6 expression in primary TNBCs [4]. Here, DUSP6 is linked to breast carcinoma.